HBM Capital Partners

HBM Capital is a prominent Swiss-based investment firm dedicated to the global healthcare sector, managing approximately $2.8 billion in assets. Founded in 2001, the firm specializes in venture capital, private equity, and public equity investments across biotechnology, pharmaceuticals, medical technology, and diagnostics. Its flagship investment vehicle, HBM Healthcare Investments AG, is publicly traded on the SIX Swiss Exchange and provides a diversified portfolio of high-growth healthcare companies. HBM Capital is known for its active investment approach, often taking board seats and providing strategic guidance to its portfolio companies from late-stage development through to commercialization. The firm maintains a global presence with a primary focus on innovation-driven markets in North America and Europe.